ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 193 filers reported holding ANIKA THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 13.64 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $1,510,000 | +25.0% | 27,512 | -7.5% | 0.01% | +33.3% |
Q2 2019 | $1,208,000 | +166.7% | 29,735 | +254.1% | 0.01% | +200.0% |
Q4 2017 | $453,000 | -7.0% | 8,398 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $487,000 | +12.5% | 8,398 | -5.1% | 0.00% | 0.0% |
Q4 2016 | $433,000 | +0.9% | 8,849 | -1.3% | 0.00% | -25.0% |
Q3 2016 | $429,000 | -19.8% | 8,965 | -36.0% | 0.00% | -20.0% |
Q4 2015 | $535,000 | -88.0% | 14,012 | 0.0% | 0.01% | 0.0% |
Q3 2015 | $4,460,000 | +920.6% | 14,012 | +5.9% | 0.01% | +25.0% |
Q2 2015 | $437,000 | -18.5% | 13,234 | +1.6% | 0.00% | 0.0% |
Q1 2015 | $536,000 | +4.3% | 13,028 | +3.2% | 0.00% | 0.0% |
Q4 2014 | $514,000 | -2.7% | 12,624 | -12.4% | 0.00% | 0.0% |
Q3 2014 | $528,000 | -17.6% | 14,416 | +4.2% | 0.00% | -33.3% |
Q2 2014 | $641,000 | +15.7% | 13,836 | +2.6% | 0.01% | +20.0% |
Q1 2014 | $554,000 | -18.4% | 13,484 | -33.9% | 0.01% | -28.6% |
Q4 2013 | $679,000 | +169.4% | 20,406 | +93.8% | 0.01% | +133.3% |
Q3 2013 | $252,000 | – | 10,528 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Euclidean Technologies Management, LLC | 42,375 | $1,225,000 | 2.02% |
CAPITAL MANAGEMENT CORP /VA | 92,905 | $2,686,000 | 0.98% |
Avidity Partners Management LP | 168,000 | $4,857,000 | 0.67% |
DIKER MANAGEMENT LLC | 21,935 | $634,000 | 0.27% |
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | 1,327,397 | $38,375,000 | 0.22% |
Intercontinental Wealth Advisors, LLC | 12,468 | $360,000 | 0.19% |
Boston Trust Walden Corp | 326,319 | $9,434,000 | 0.15% |
Matarin Capital Management, LLC | 32,599 | $942,000 | 0.15% |
Cove Street Capital, LLC | 20,000 | $578,000 | 0.12% |
OAKTOP CAPITAL MANAGEMENT II, L.P. | 12,500 | $361,000 | 0.11% |